Skip to main content

Advertisement

ADVERTISEMENT

Volume 17 - Issue 1 - January, 2005

08/01/2008
Clopidogrel is an oral antiplatelet agent which selectively and irreversibly inhibits the platelet adenosine 5'-diphosphate (ADP) receptor. Antiplatelet effect is synergistic when administered with aspirin. Dual antiplatelet therapy with...
Clopidogrel is an oral antiplatelet agent which selectively and irreversibly inhibits the platelet adenosine 5'-diphosphate (ADP) receptor. Antiplatelet effect is synergistic when administered with aspirin. Dual antiplatelet therapy with...
Clopidogrel is an oral...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Ostial atherosclerotic lesions constitute a distinct substrate for percutaneous interventions, as they differ from the other lesion sites in management strategies and in clinical outcomes. Since the lesions are more likely fibrotic and...
Ostial atherosclerotic lesions constitute a distinct substrate for percutaneous interventions, as they differ from the other lesion sites in management strategies and in clinical outcomes. Since the lesions are more likely fibrotic and...
Ostial atherosclerotic lesions...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Coronary interventions of non-aorto ostial stenoses remain a challenging task with a high rate of procedural complications and restenosis. The lack of efficacy of conventional balloon angioplasty in non-aorto ostial coronary intervention has...
Coronary interventions of non-aorto ostial stenoses remain a challenging task with a high rate of procedural complications and restenosis. The lack of efficacy of conventional balloon angioplasty in non-aorto ostial coronary intervention has...
Coronary interventions of...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Although primary percutaneous coronary intervention (PCI) has been proven to be superior to thrombolytic therapy for the treatment of acute ST-elevation myocardial infarction (STEMI),1–3 the latter approach is still widely practiced due to...
Although primary percutaneous coronary intervention (PCI) has been proven to be superior to thrombolytic therapy for the treatment of acute ST-elevation myocardial infarction (STEMI),1–3 the latter approach is still widely practiced due to...
Although primary percutaneous...
08/01/2008
Journal of Invasive Cardiology

Insights

Commentary
08/01/2008
Despite several studies showing an advantage of early treatment with clopidogrel in the patient presenting with acute coronary syndrome, or prior to percutaneous coronary intervention (PCI),1–6 this treatment is frequently not given early...
Despite several studies showing an advantage of early treatment with clopidogrel in the patient presenting with acute coronary syndrome, or prior to percutaneous coronary intervention (PCI),1–6 this treatment is frequently not given early...
Despite several studies showing...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
This prospective observational study examines the use of sirolimus-eluting stents (SES) for the treatment of atherosclerotic ostial lesions.1 Ostial lesions that involve the junction of the aorta and the origin of the right coronary artery,...
This prospective observational study examines the use of sirolimus-eluting stents (SES) for the treatment of atherosclerotic ostial lesions.1 Ostial lesions that involve the junction of the aorta and the origin of the right coronary artery,...
This prospective observational...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Percutaneous treatment of patients with a visible intracoronary thrombus has been recognized as a procedure associated with higher risk for complications. For patients with intracoronary thrombus in the stent era, the potentially worse...
Percutaneous treatment of patients with a visible intracoronary thrombus has been recognized as a procedure associated with higher risk for complications. For patients with intracoronary thrombus in the stent era, the potentially worse...
Percutaneous treatment of...
08/01/2008
Journal of Invasive Cardiology

Feature

Original Contribution
08/01/2008
Percutaneous coronary intervention (PCI) on thrombus-containing lesions represents a clinical challenge to the interventional cardiologist, since thrombus has been identified as a predictor of adverse outcome.1,2 While attempting to...
Percutaneous coronary intervention (PCI) on thrombus-containing lesions represents a clinical challenge to the interventional cardiologist, since thrombus has been identified as a predictor of adverse outcome.1,2 While attempting to...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement